Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

1.17
Delayed Data
As of 4:02pm ET
 -0.01 / -0.85%
Today’s Change
0.86
Today|||52-Week Range
2.15
+33.71%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close1.18
Today’s open1.18
Day’s range1.12 - 1.19
Volume268,240
Average volume (3 months)551,525
Market cap$69.0M
Dividend yield--
Data as of 4:02pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)+9.09%
Earnings growth (this year)-11.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.66

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...+0.07+2.07%
XENEXenon Pharmaceutical...-0.80-21.05%
SNSSSunesis Pharmaceutic...-0.23-7.26%
IMMYImprimis Pharmaceuti...-0.03-0.89%
Data as of 4:00pm ET, 06/27/2017

Financials

Next reporting dateJuly 31, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$24.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Sandesh Seth
Chief Financial &
Accounting Officer
Steve Oloughlin
Corporate headquarters
New York, New York

Forecasts